Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Among authors: toto rd. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. N Engl J Med. 2020. PMID: 32970396 Free article. Clinical Trial.
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease.
McMurray JJV, Wheeler DC, Stefánsson BV, Jongs N, Postmus D, Correa-Rotter R, Chertow GM, Greene T, Held C, Hou FF, Mann JFE, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. McMurray JJV, et al. Among authors: toto rd. Circulation. 2021 Feb 2;143(5):438-448. doi: 10.1161/CIRCULATIONAHA.120.051675. Epub 2020 Nov 13. Circulation. 2021. PMID: 33186054 Clinical Trial.
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.
Heerspink HJL, Stefansson BV, Chertow GM, Correa-Rotter R, Greene T, Hou FF, Lindberg M, McMurray J, Rossing P, Toto R, Langkilde AM, Wheeler DC; DAPA-CKD Investigators. Heerspink HJL, et al. Nephrol Dial Transplant. 2020 Feb 1;35(2):274-282. doi: 10.1093/ndt/gfz290. Nephrol Dial Transplant. 2020. PMID: 32030417 Free PMC article. Clinical Trial.
Impact of race on renal transplant outcome.
Dawidson IJ, Coorpender L, Fisher D, Helderman H, Hull A, Palmer B, Peters P, Sagalowsky A, Sandor ZF, Toto R, et al. Dawidson IJ, et al. Transplantation. 1990 Jan;49(1):63-7. doi: 10.1097/00007890-199001000-00014. Transplantation. 1990. PMID: 2301030
Hypertension and the failing kidney.
Toto RD. Toto RD. Curr Opin Nephrol Hypertens. 2001 Mar;10(2):165-6. doi: 10.1097/00041552-200103000-00002. Curr Opin Nephrol Hypertens. 2001. PMID: 11224689 Review. No abstract available.
A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease.
Ferreira RM, Gisch DL, Phillips CL, Cheng YH, Asthana M, Lake BB, Bowen WS, Fang F, Asghari M, Sabo A, Barwinska D, Ferkowicz MJ, Toto RD, Sedor JR, Rosas SE, Bjornstad P, Hodgin JB, Alpers CE, Sarder P, Himmelfarb J, Schaub JA, Nair V, Winfree S, Sutton TA, Kelly KJ; Kidney Precision Medicine Project; Kretzler M, Jain S, El-Achkar TM, Dagher PC, Eadon MT. Ferreira RM, et al. Among authors: toto rd. bioRxiv [Preprint]. 2024 Dec 31:2024.09.27.615250. doi: 10.1101/2024.09.27.615250. bioRxiv. 2024. PMID: 39803522 Free PMC article. Preprint.
211 results